Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.